Literature DB >> 16269620

CD11c+ dendritic cells and plasmacytoid DCs are activated by human cytomegalovirus and retain efficient T cell-stimulatory capability upon infection.

Espen Ø Kvale1, Jakob Dalgaard, Fridtjof Lund-Johansen, Halvor Rollag, Lorant Farkas, Karsten Midtvedt, Frode L Jahnsen, Jan E Brinchmann, Johanna Olweus.   

Abstract

It has been suggested that human cytomegalovirus (HCMV) evades the immune system by infecting and paralyzing antigen-presenting cells. This view is based mainly on studies of dendritic cells (DCs) obtained after culture of monocytes (moDCs). It is contradicted by the asymptomatic course of HCMV infection in healthy persons, indicating that other key antigen-presenting cells induce an efficient immune response. Here we show that HCMV activates CD11c+ DCs and plasmacytoid DCs (PDCs). In contrast to moDCs, CD11c+ DCs and PDCs produced interferon (IFN) type 1 when exposed to HCMV. Autocrine IFN type 1 partially protected CD11c+ DCs against infection, whereas PDCs were resistant to HCMV even when IFN type 1 activity was inhibited. HCMV exposure induced the maturation of CD11c+ DCs by IFN type 1-dependent and -independent mechanisms. Importantly, CD11c+ DCs infected by inhibiting IFN type 1 activity retained full capacity to stimulate T cells. Renal transplant recipients receiving immunosuppressive treatment had lower frequencies of CD11c+ DCs and PDCs in blood than did healthy controls. The results show that HCMV activates the immune system by interacting with CD11c+ DCs and PDCs and that recipients of renal transplants have low frequencies of these cell types in blood.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16269620     DOI: 10.1182/blood-2005-05-2016

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  27 in total

Review 1.  Modulation of host innate and adaptive immune defenses by cytomegalovirus: timing is everything.

Authors:  A Loewendorf; C A Benedict
Journal:  J Intern Med       Date:  2010-05       Impact factor: 8.989

2.  Characterization of plasmacytoid dendritic cells in bone marrow of pig-tailed macaques.

Authors:  R Keith Reeves; Patricia N Fultz
Journal:  Clin Vaccine Immunol       Date:  2007-11-07

Review 3.  The tiers and dimensions of evasion of the type I interferon response by human cytomegalovirus.

Authors:  Lisi Amsler; Marieke Verweij; Victor R DeFilippis
Journal:  J Mol Biol       Date:  2013-09-05       Impact factor: 5.469

Review 4.  The tug-of-war between dendritic cells and human chronic viruses.

Authors:  Saifur Rahman; Zafar K Khan; Pooja Jain
Journal:  Int Rev Immunol       Date:  2011 Oct-Dec       Impact factor: 5.311

5.  Circulating dendritic cells isolated from healthy seropositive donors are sites of human cytomegalovirus reactivation in vivo.

Authors:  Matthew B Reeves; John H Sinclair
Journal:  J Virol       Date:  2013-07-24       Impact factor: 5.103

Review 6.  Diverse immune evasion strategies by human cytomegalovirus.

Authors:  Vanessa Noriega; Veronika Redmann; Thomas Gardner; Domenico Tortorella
Journal:  Immunol Res       Date:  2012-12       Impact factor: 2.829

7.  Attenuation of innate immunity by cytomegalovirus IL-10 establishes a long-term deficit of adaptive antiviral immunity.

Authors:  W L William Chang; Peter A Barry
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-13       Impact factor: 11.205

8.  Common variable immunodeficiency revisited: normal generation of naturally occurring dendritic cells that respond to Toll-like receptors 7 and 9.

Authors:  E Taraldsrud; B Fevang; P Aukrust; K H Beiske; Y Fløisand; S Frøland; H Rollag; J Olweus
Journal:  Clin Exp Immunol       Date:  2014-03       Impact factor: 4.330

9.  Human cytomegalovirus suppresses type I interferon secretion by plasmacytoid dendritic cells through its interleukin 10 homolog.

Authors:  W L William Chang; Peter A Barry; Richard Szubin; Dai Wang; Nicole Baumgarth
Journal:  Virology       Date:  2009-06-13       Impact factor: 3.616

Review 10.  Influence of dendritic cells on viral pathogenicity.

Authors:  Giulia Freer; Donatella Matteucci
Journal:  PLoS Pathog       Date:  2009-07-31       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.